製品の概要

  • 製品名SB 203580
  • 製品の詳細
    p38 MAPK inhibitor
  • 生理活性の詳細Cell-permeable p38 MAPK inhibitor. Shows selectivity over many other kinases but also shown to have some inhibitory activity against GAK, CK1, RIP2, c-Raf and GSK3.
  • 精製度> 99%

製品の特性

    SB 203580 (ab120162) 使用論文

    This product has been referenced in:
    • Cuenda A & Rousseau S p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 1773:1358-75 (2007). Read more (PubMed: 17481747) »
    • Bain J  et al. The selectivity of protein kinase inhibitors: a further update. Biochem J 408:297-315 (2007). Read more (PubMed: 17850214) »
    • Kumar S  et al. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun 263:825-31 (1999). Read more (PubMed: 10512765) »

    See all 6 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120162.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"